Comparison of s- and d-wave gap symmetry in nonequilibrium superconductivity

Recent application of ultrafast pump/probe optical techniques to superconductors has renewed interest in nonequilibrium superconductivity and the predictions that would be available for novel superconductors, such as the high-Tc cuprates. We have reexamined two of the classical models which have been used in the past to interpret nonequilibrium experiments with some success: the mu* model of Owen and Scalapino and the T* model of Parker. Predictions depend on pairing symmetry. For instance, the gap suppression due to excess quasiparticle density n in the mu* model, varies as n^{3/2} in d-wave as opposed to n for s-wave. Finally, we consider these models in the context of S-I-N tunneling and optical excitation experiments. While we confirm that recent pump/probe experiments in YBCO, as presently interpreted, are in conflict with d-wave pairing, we refute the further claim that they agree with s-wave.Comment: 14 pages, 11 figure

Toric G_2 and Spin(7) holonomy spaces from gravitational instantons and other examples

Non-compact G_2 holonomy metrics that arise from a T^2 bundle over a hyper-Kahler space are discussed. These are one parameter deformations of the metrics studied by Gibbons, Lu, Pope and Stelle in hep-th/0108191. Seven-dimensional spaces with G_2 holonomy fibered over the Taub-Nut and the Eguchi-Hanson gravitational instantons are found, together with other examples. By considering the Apostolov-Salamon theorem math.DG/0303197, we construct a new example that, still being a T^2 bundle over hyper-Kahler, represents a non trivial two parameter deformation of the metrics studied in hep-th/0108191. We then review the Spin(7) metrics arising from a T^3 bundle over a hyper-Kahler and we find two parameter deformation of such spaces as well. We show that if the hyper-Kahler base satisfies certain properties, a non trivial three parameter deformations is also possible. The relation between these spaces with the half-flat structures and almost G_2 holonomy spaces is briefly discussed.Comment: 27 pages. Typos corrected. Accepted for publication in Commun.Math.Phy

Lepton flavor violating signals of a little Higgs model at the high energy linear e+e−e^{+}e^{-} colliders

Littlest Higgs $(LH)$ model predicts the existence of the doubly charged scalars $\Phi^{\pm\pm}$, which generally have large flavor changing couplings to leptons. We calculate the contributions of $\Phi^{\pm\pm}$ to the lepton flavor violating $(LFV)$ processes $l_{i}\to l_{j}\gamma$ and $l_{i}\to l_{j}l_{k}l_{k}$, and compare our numerical results with the current experimental upper limits on these processes. We find that some of these processes can give severe constraints on the coupling constant $Y_{ij}$ and the mass parameter $M_{\Phi}$. Taking into account the constraints on these free parameters, we further discuss the possible lepton flavor violating signals of $\Phi^{\pm\pm}$ at the high energy linear $e^{+}e^{-}$ collider $(ILC)$ experiments. Our numerical results show that the possible signals of $\Phi^{\pm\pm}$ might be detected via the subprocesses $e^{\pm}e^{\pm}\to l^{\pm}l^{\pm}$ in the future $ILC$ experiments.Comment: 16 pages, 7 figures. Discussions and references added, typos correcte

The preparation of HEMA-MPC films for ocular drug delivery

There is a need to prolong drug residence time using a biocompatible formulation in the subconjunctival space after surgery to treat glaucoma. Drug releasing discs were prepared with 2-(hydroxyethyl)methacrylate (HEMA) and 2-methacryloyl-oxyethyl phosphorylcholine (MPC). The ratio of bound water (Wb) to free water (Wf) ratio increased from 1:0.3 to 1:6.8 with increasing MPC (0 to 50%, w/w). The optimal balance between water content, SR and mechanical strength were obtained with 10% MPC (w/w) hydrogels. Water-alcohol mixtures were examined to facilitate loading of poorly soluble drugs, and they showed greater hydrogel swelling than either water or alcohol alone. The SR was 1.2 ± 0.02 and 3.3 ± 0.1 for water and water:ethanol (1:1) respectively. HEMA-MPC (10%) discs were loaded with dexamethasone using either water:ethanol (1:1) or methanol alone. Drug release was examined in an outflow rig model that mimics the subconjunctival space in the eye. Dexamethasone loading increased from 0.3 to 1.9 mg/disc when the solvent was changed from water:ethanol (1:1) to methanol with the dexamethasone half-life (t½) increasing from 1.9 to 9.7 days respectively. These encouraging results indicate that HEMA-MPC hydrogels have the potential to sustain the residence time of a drug in the subconjunctival space of the eye

Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema : Subgroup analysis of the MEAD study

Background: Dexamethasone intravitreal implant 0.7 mg (DEX 0.7) was approved for treatment of diabetic macular edema (DME) after demonstration of its efficacy and safety in the MEAD registration trials. We performed subgroup analysis of MEAD study results to evaluate the efficacy and safety of DEX 0.7 treatment in patients with previously treated DME. Methods: Three-year, randomized, sham-controlled phase 3 study in patients with DME, best-corrected visual acuity (BCVA) of 34.68 Early Treatment Diabetic Retinopathy Study letters (20/200.20/50 Snellen equivalent), and central retinal thickness (CRT) 65300 \u3bcm measured by time-domain optical coherence tomography. Patients were randomized to 1 of 2 doses of DEX (0.7 mg or 0.35 mg), or to sham procedure, with retreatment no more than every 6 months. The primary endpoint was 6515-letter gain in BCVA at study end. Average change in BCVA and CRT from baseline during the study (area-under-the-curve approach) and adverse events were also evaluated. The present subgroup analysis evaluated outcomes in patients randomized to DEX 0.7 (marketed dose) or sham based on prior treatment for DME at study entry. Results: Baseline characteristics of previously treated DEX 0.7 (n = 247) and sham (n=261) patients were similar. In the previously treated subgroup, mean number of treatments over 3 years was 4.1 for DEX 0.7 and 3.2 for sham, 21.5 % of DEX 0.7 patients versus 11.1 % of sham had 6515-letter BCVA gain from baseline at study end (P = 0.002), mean average BCVA change from baseline was +3.2 letters with DEX 0.7 versus +1.5 letters with sham (P = 0.024), and mean average CRT change from baseline was -126.1 \u3bcm with DEX 0.7 versus -39.0 \u3bcm with sham(P < 0.001). Cataract-related adverse events were reported in 70.3 % of baseline phakic patients in the previously treated DEX 0.7 subgroup; vision gains were restored following cataract surgery. Conclusions: DEX 0.7 significantly improved visual and anatomic outcomes in patients with DME previously treated with laser, intravitreal anti-vascular endothelial growth factor, intravitreal triamcinolone acetonide, or a combination of these therapies. The safety profile of DEX 0.7 in previously treated patients was similar to its safety profile in the total study population

A prototype simulator for endovascular repair of abdominal aortic aneurysms

A prototype simulator for training in endovascular repair of abdominal aortic aneurysms (AAA) has been developed. Employing transparent models of human AAA complete with renal, iliac and femoral arteries, this system allows accurate simulation of aortography, road-mapping, catheter guidewire manipulation and stent-graft deployment while obviating the need for ionising radiation

Large-scale synthesis of Fe3O4 nanosheets at low temperature

10.1021/jp070873gJournal of Physical Chemistry C111269136-914